Home / Themes / Euro Spend '25: Chemicals & Clean Tech
Euro Spend '25: Chemicals & Clean Tech
Last updated
Theme thesis · 3/5 sections · Tickers 2 with notes · 7 pending
Bull / Bear Details has the investment thesis and bull/bear points. Overview is monitoring guidance (hiring, forums, second-order trends, search keywords, Google Trends, datasets).
Bull / Bear DetailsEurope is funneling fiscal investment into strategic chemicals and clean-tech inputs essential to industrial sovereignty, decarbonization, and re-shoring. This
Thesis
Europe is funneling fiscal investment into strategic chemicals and clean-tech inputs essential to industrial sovereignty, decarbonization, and re-shoring. This subtheme benefits directly from industrial policy targeting circular materials, green chemistry, and emissions-efficient production.
Bull case
Green Industrial Inputs Get Priority: The Draghi report and Competitiveness Compass prioritize “low-carbon enablers” and incentivize next-gen chemicals for batteries, EVs, hydrogen, and energy storage.
Air Liquide and BASF Anchor Clean Tech: Firms with CAPEX scale and adjacent clean tech (electrolysis, gas separation, CCUS) are receiving joint subsidies and national grants.
Reshoring & Regionalization of Supply Chains: Clariant, Lanxess, and Wacker benefit from EU push to reduce dependency on Asian specialty chemical chains for pharma, solar, and chip materials.
Bear case
Structural Overcapacity in Europe: Chemical plants shuttered in 2022–23 may not return as cost inflation and regulatory friction persist in Western Europe vs U.S./Gulf/China.
Policy Fatigue or Greenlash: Voter pushback on green fiscal initiatives could slow grant issuance or redirect funds toward energy security rather than sustainability.
Demand-Driven Earnings Risk: Weak global manufacturing cycle and China export softness could limit volume leverage despite fiscal support.
Key Metrics
| Metric | Cadence | What It Signals | Update Source |
|---|---|---|---|
| EU Clean Hydrogen & CCUS Project Funding Issued | Monthly | Pipeline of green chemical inputs (e.g. Air Liquide electrolysis, BASF blue ammonia) | Google_Sheets |
| CAPEX & R&D Spend YoY (BASF, Air Liquide, Arkema) | Quarterly | Tracks fiscal grant absorption + strategic reinvestment into clean tech platforms | Google_Sheets |
| EU Specialty & Industrial Chemical Output Index | Monthly | Real-time read on production recovery and CAPEX-fueled expansion | Google_Sheets |
Upcoming Catalysts
| Catalyst ID | Estimated Timing | Estimated Date Start | Estimated Date End | Catalyst | Why It Matters | Ticker Or Theme Specific | Transcript Date | Source Type | Catalyst Source |
|---|---|---|---|---|---|---|---|---|---|
| AKE.PA_e9038a17 | PVDF US start-up planned to start up in the first half of 2026 | 2026-01-01 | 2026-06-30 | Start-up of PVDF capacity in the United States, increasing regional capacity by 15%. | Catalyzes additional high-margin polymer production in a key market, with potential EBITDA uplift if ramp-up meets plan; delays or cost overruns could weigh on margins and timing of benefits. | Ticker | 2026-02-26 | earnings_transcript | AKE.PA (ticker) |
| AKE.PA_6ce71e07 | Ramping up major projects in 2026 contributing around EUR 50 million of additional EBITDA | 2026-01-01 | 2026-12-31 | Ramp-up of major projects (including 1233zd US, DMDS US, and Rilsan Clear in Singapore) expected to contribute ~EUR 50 million of additional EBITDA in 2026. | Represents a meaningful driver of near-term earnings and cash generation; if slower, it could temper guidance and investor sentiment. | Ticker | 2026-02-26 | earnings_transcript | AKE.PA (ticker) |
| AKE.PA_543c78bb | starting in 2026 | 2026-01-01 | 2026-12-31 | Implementation of a new segmentation starting in 2026 to separate Specialty Materials from Primary Materials (including polyamide business) for better portfolio visibility. | Increases transparency for investors and could impact valuation/interpretation of segments; restructuring could affect reported metrics and investor perception. | Ticker | 2026-02-26 | earnings_transcript | AKE.PA (ticker) |
| WCH.XETRA_89902857 | The statutory deadline for the final report is March 28, 2026, with the President needing to concur with findings within 90 days (on or about June 26, 2026). | 2026-03-28 | 2026-06-26 | Final ruling and presidential decision on the Section 232 investigation into imported polysilicon and its derivatives in the U.S. solar market. | The outcome will determine the attractiveness of the U.S. solar market for Wacker Chemie's solar-grade polysilicon, potentially impacting demand and profitability for this segment. A clear decision could allow Wacker to assess opportunities or consider asset optimization if the market remains unattractive. | Ticker | 2025-10-30 | earnings_transcript | WCH.XETRA (ticker) |
| WCH.XETRA_253eacc7 | increasing volumes to be sold next year, coming also from our hedging line. | 2026-01-01 | 2026-12-31 | Continued ramp-up and increased sales volumes of hyperpure semiconductor-grade polysilicon from Wacker Chemie's new etching line. | This is expected to provide an upside to EBITDA for the Polysilicon segment, supporting strong growth in the semiconductor business and offsetting some headwinds from the solar market. | Ticker | 2025-10-30 | earnings_transcript | WCH.XETRA (ticker) |
| AKE.PA_9d5b5502 | 2028 cumulative cost savings target of EUR 250 million, 2 years in advance | 2028-01-01 | 2028-12-31 | Delivery of EUR 250 million in cost savings by 2028, achieved two years earlier than planned. | Material potential improvement to margins and cash flow, reducing sensitivity to input cost inflation and potentially supporting multiple expansion if achieved. | Ticker | 2026-02-26 | earnings_transcript | AKE.PA (ticker) |
Constituents
- AKE.PAT3— Arkema S.A.
- — Wacker Chemie AG
- AI.PAT3· no notes yet
- ALFA.STT3· no notes yet
- BAS.XETRAT3· no notes yet
- CLN.SWT3· no notes yet
- CRDA.LSET3· no notes yet
- EVK.XETRAT3· no notes yet
- LXS.XETRAT3· no notes yet